Pure Financial Advisors LLC bought a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 7,196 shares of the company’s stock, valued at approximately $609,000.
A number of other large investors also recently modified their holdings of the company. BlackRock Inc. acquired a new position in Corteva in the 2nd quarter worth about $4,560,180,000. Harris Associates L P boosted its stake in shares of Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares in the last quarter. Norges Bank bought a new stake in shares of Corteva during the fourth quarter worth about $504,001,000. Jupiter Topco LLC acquired a new position in shares of Corteva in the second quarter valued at approximately $544,246,000. Finally, Bank of America Corp DE bought a new position in Corteva in the 2nd quarter valued at approximately $484,927,000. 81.54% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have issued reports on CTVA. UBS Group decreased their price target on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a research report on Tuesday, August 18th. Royal Bank Of Canada raised their target price on Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 21st. JPMorgan Chase & Co. upped their price target on Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Citigroup lifted their price objective on Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Finally, Bank of America boosted their target price on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $91.50.
Corteva Stock Performance
Shares of CTVA opened at $83.08 on Thursday. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The company has a market cap of $55.43 billion, a PE ratio of 55.02, a P/E/G ratio of 2.55 and a beta of 0.57. The stock has a 50-day moving average of $82.51 and a 200-day moving average of $80.45. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10.
Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities research analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.
Corteva Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 47.68%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
- Five stocks we like better than Corteva
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
